As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Women's health is in fact a direct reflection of the nation's overall health
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Dr Ratna Puri from Sir Ganga Ram Hospital, Delhi is the Chairperson of the expert committee.
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Subscribe To Our Newsletter & Stay Updated
